|
PerkinElmer
to strengthen global presence through alliances
PERKINELMER Inc, USA, a leading provider of drug discovery, life
science research and analytical solutions, after announcing its
51:49 joint venture in India with the Mumbai-based Lab India is
looking at strengthening its presence at different global destinations.
Wockhardt
acquires German company for Rs 49 crore
CITY-based drug major Wockhardt has acquired the business of German
drug maker Esparma GmbH for a consideration of US dollar 11 million
(Rs 49 cr).
Dr
Reddy’s acquires US dermatology company
CITY-based pharma major Dr Reddy’s Laboratories announced that
the company has acquired Trigenesis Therapeutics Inc, a US-based
privately-owned dermatology company.
Li
Taka Pharma board meeting on May 14
A meeting of the board of directors of Li Taka Pharmaceuticals Ltd
would be held on May 14, 2004 to consider the proposal to make Rights
Issue of shares to the shareholders of the company.
GSK
moves SC over drug price controls
PHARMA major GalxoSmithKline (GSK) won’t give up its fight
for a more rational drug price control regime. GSK has filed a special
leave petition (SLP) in the Supreme Court, challenging a recent
Bombay High Court order against it.
Johnson
Matthey opens new facility in Maharashtra
THE 4.3 billion pound UK based Johnson Matthey Group opened its
new ’precious metal Process catalyst’ facility at MIDC,
Taloja, Maharashtra.
DRL
shifts US HQ to New Jersey
DR Reddy’s Laboratories Ltd has shifted its North American
headquarters from its old home office in Upper Saddle River in New
Jersey to more modern facilities in the Somerset Corporate Centre
at Bridgewater in central New Jersey, said a release.
Wockhardt
to start human trials on new compound
Mumbai - based Wockhardt Ltd is set to start human trials on its
antibacterial compound for treating respiratory infection.
Sun
Pharma shareholders okay rejig in investments
The shareholders of Sun Pharmaceuticals Ltd approved investments
in shares
Ind
Swift PAT zooms 137 pc to Rs 5 cr
Ind Swift Ltd has reported a 137 per cent rise in profit after tax
to Rs 4.93 crore for the last quarter ended March 2004, up from
Rs 2.11 crore reported in the corresponding quarter last year.
Dabur
India records 41 pc surge in FY04 net profit
Dabur India Ltd reported a 40.6 per cent increase in net profit
to Rs 101.20 crore for the year-ended March 31, 2004 from Rs 72
crore recorded, last year.
|
